Cardio Diagnostics Holdings partners with Navierre for cardiac testing
AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible. Cardio Diagnostics Holdings’ AI solutions, Epi+GenCHD and PrecisionCHD, use blood…
Continue Reading